Factors Influencing Treatment Decision-Making In Patients With BRAF-Mutated Metastatic Melanoma
November 30th 2023
Beyond symptoms, doctors consider the psychosocial factors impacting treatment access and adherence, like insurance coverage, cost, family support, and preexisting conditions, when deciding between immunotherapy and targeted therapy for patients with BRAF-mutated metastatic melanoma.